The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Public health actions to control new SARS-CoV-2 variants
Open accessAbstract
Recent reports suggest that some SARS-CoV-2 genetic variants, such as B.1.1.7, might be more transmissible and are quickly spreading around the world. As the emergence of more transmissible variants could exacerbate the pandemic, we provide public health guidance for increased surveillance and measures to reduce community transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557
Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., et al. (2020) · doi:10.1101/2020.12.21.20248640 · Cited by 2,535 · cited 2×
“In late 2020, genomic surveillance in South Africa revealed a new SARSCoV-2 variant (designated B.1.351 or 501Y.V2) associated with a concerning rise in local COVID-19 cases (Tegally et al., 2020).”
BackgroundInfluentialDetection of a SARS-CoV-2 variant of concern in South Africa
Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., et al. (2021) · Nature · doi:10.1038/s41586-021-03402-9 · Cited by 2,510
Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.012 · Cited by 1,956
Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., O’Toole, Á., et al. (2021) · doi:10.1101/2020.12.30.20249034 · Cited by 1,611 · cited 1×
“…estimated that B.1.1.7 is approximately 50% more transmissible (Davies et al., 2020), which could increase the average number of people that one infected person will pass the virus to (effective reproductive rate) by between 0.4 and 0.7 people (Volz et al., 2021).”
BackgroundInfluentialAssessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., et al. (2021) · Nature · doi:10.1038/s41586-021-03470-x · Cited by 1,611
Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · doi:10.1101/2020.12.31.425021 · Cited by 1,178 · cited 2×
“One of the mutations in this variant, N501Y, is located in the important receptor-binding domain (RBD) of spike protein, and is predicted to increase binding to human cells and reduce viral neutralization by the monoclonal antibody LY-CoV016 (Greaney et al., 2021; Starr et al., 2020).”
BackgroundGreaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.003 · Cited by 1,178
Research works printed but not linked: 1
- Davies, 2020, Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England, medRxiv
Cited by
Sorted by citations
Items 101–146 of 146
Oláiz, G., Bertozzi, S., Juárez-Flores, A., Borja‐Aburto, V. H., Anda, F. J. V.-D., Ascencio-Montiel, I. D. J., & Gutiérrez, J. P. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1102498 · Cited by 3
A high-resolution melt curve toolkit to identify lineage-defining SARS-CoV-2 mutations
Fraser, A. J., Greenland-Bews, C., Kelly, D. F., Williams, C. T., LSTM Diagnostics Group, Bengey, D., Buist, K., Clerkin, K., Finch, L. S., Gould, S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-30754-1 · Cited by 3
Optimal capacity sharing for global genomic surveillance
Méder, Z. Z., & Somogyi, R. (2023) · Epidemics · doi:10.1016/j.epidem.2023.100690 · Cited by 3
Genomic monitoring of SARS‐CoV‐2 variants using sentinel SARI hospital surveillance
Denayer, S., Dufrasne, F. E., Monsieurs, B., van Eycken, R., Houben, S., Seyler, L., Demuyser, T., Nedervelde, E. V., Bourgeois, M., Delaere, B., et al. (2023) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13202 · Cited by 3
Zhang, P.-W., Zhang, S. H., Li, W., Keuthan, C. J., Li, S., Takaesu, F., Berlinicke, C. A., Wan, J., Sun, J., & Zack, D. J. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104225 · Cited by 3
Maple, P. A. C. (2021) · Vaccines · doi:10.3390/vaccines9060550 · Cited by 3
From partial to whole genome imputation of SARS-CoV-2 for epidemiological surveillancePreprint
Ortuño, F. M., Loucera, C., Casimiro‐Soriguer, C. S., Lepe, J. A., Camacho‐Martínez, P., Díaz, L. M., de Salazar, A., Chueca, N., García, F., Pérez-Florido, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.13.439668 · Cited by 3
Choi, A., Singleton, D. T., Stout, A. E., Millet, J. K., & Whittaker, G. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.16.473025 · Cited by 3
A Convenient and Cost Efficient Route Suitable for “One-Pot” Synthesis of MolnupiravirPreprint
Hu, T., Xie, Y., Liu, Y., Xue, H., Zhu, F., Aisa, H. A., & Shen, J. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14208206 · Cited by 3
WEPP: Phylogenetic placement achieves near-haplotype resolution in wastewater-based epidemiology
Gangwar, P., Katte, P., Bhat, M., & Turakhia, Y. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014124 · Cited by 2
Salazar, C., Costábile, A., Ferrés, I., Perbolianachis, P., Pereira-Gómez, M., Simón, D., Galiana, A., Pi, B., Antelo, V., García, R., et al. (2021) · Frontiers in Virology · doi:10.3389/fviro.2021.685618 · Cited by 2
Belmouhoub, M., Aberkane, B., Tacherfiout, M., Boukhalfa, F., Khodja, Y. K., & Bachir‐bey, M. (2024) · Ethnobotany Research and Applications · doi:10.32859/era.28.42.1-26 · Cited by 2
Shiraly, R., Khoshdel, N., Jeihooni, A. K., & McLaws, M. (2022) · BMC Public Health · doi:10.1186/s12889-022-13184-y · Cited by 2
Evolving COVID-19 Pandemic: The Lurking Dangers and Pillars of Hope
Nikhra, V. (2021) · Annals of Immunology & Immunotherapy · doi:10.23880/aii-16000135 · Cited by 1
Alexiev, I., Ivanov, I. N., Stoikov, I., Donchev, D., Grigorova, L., Dimitrova, R., Gancheva, A., Korsun, N., Trifonova, I. T., Dobrinov, V., et al. (2023) · PROBLEMS of Infectious and Parasitic Diseases · doi:10.58395/6725v303 · Cited by 2
Unlocking capacities of viral genomics for the COVID-19 pandemic responsePreprint
Knyazev, S., Chhugani, K., Sarwal, V., Ayyala, R., Singh, H., Karthikeyan, S., Deshpande, D., Comarova, Z., Lu, A., Porozov, Y. B., et al. (2021) · PubMed · doi:10.48550/arxiv.2104.14005 · Cited by 2
How much should we sequence? An analysis of the Swiss SARS-CoV-2 surveillance effortPreprint
Wegner, F., Gil, B. C., Araud, T., Beckmann, C., Beerenwinkel, N., Bertelli, C., Carrara, M., Cerutti, L., Chen, C., Cordey, S., et al. (2023) · medRxiv · doi:10.1101/2023.08.28.23294715 · Cited by 2
Infectious Disease Surveillance in Vietnam: Pathogen Early Detection in Hanoi Wastewater
Taylor-Robinson, A. W., & Nguyen, T. H. (2022) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2022.00089 · Cited by 1
MIu, S., Nv, K., Belik, A. A., Persiyanova, E. V., Белов, Ю., Maĭstrovskaia, O. S., Mikhalko, A. A., Trofimova, M. F., Николаевна, П. М., Romanova, O. B., et al. (2026) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-766 · Cited by 1
Mutations in SARS-CoV-2 genomes and future strategies
Nimavat, N. K., Singh, S., Agrawal, A., Rafi, M. A., Bhatti, B., Parmar, G. R., & Shah, A. P. (2021) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2021.100875 · Cited by 1
Application of AI+5G network in the therapy and prophylaxis of major epidemics
Gong, L. (2022) · International Conference on Network Communication and Information Security (ICNCIS) · doi:10.1117/12.2657482 · Cited by 1
Development of PCR test for detection of the SARS-CoV-2 genetic variants alpha, beta, gamma, delta
Shipulin, G. A., Savochkina, Y. A., Константиновна, Ш. А., Shivlyagina, E., Nosova, A. O., Евгеньевна, Д. Е., Luparev, A. R., Владимировна, М. Т., & Yudin, S. M. (2022) · Medicine of Extreme Situations · doi:10.47183/mes.2022.003 · Cited by 1
Russell, A., O’Connor, C., Lasek‐Nesselquist, E., Plitnick, J., Kelly, J. P., Lamson, D. M., & George, K. S. (2021) · medRxiv · doi:10.1101/2021.09.14.21262977 · Cited by 1
Novel neutralization mechanism of a human antibody with pan-coronavirus reactivityPreprint
Sun, X., Yi, C., Zhu, Y., Ding, L., Xia, S., Gu, C., Lu, X., Chen, S., Yang, Z., Zhang, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-952553/v1 · Cited by 1
Olaiz, G., Bertozzi, S. M., Juárez-Flores, A., Borja‐Aburto, V. H., Vicuña, F., Ascencio-Montiel, I. J., & Gutierrez, J. P. (2022) · Research Square · doi:10.21203/rs.3.rs-1879100/v1 · Cited by 1
Barboza, J. M., Quintero, J., Sivira, A., Valeri-Ramírez, L. C., Rosa, E. R. E., & Angulo-Lacruz, C. A. (2021) · Investigación Clínica · doi:10.22209/ic.v62s2a04
Slow vaccination and immunity profile homogeny as a cause of SARS-CoV-2 antigenic drift
Khan, N. (2026) · Open Collections · doi:10.14288/ujemip.v5.203762
Predicting the Disease Severity of Virus Infection
Qi, X., Shen, L., Chen, J., Shi, M., & Shen, B. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-8969-7_6
Chen, D., Randhawa, G. S., Soltysiak, M. P. M., de Souza, C. P. E., Lila Kari, A., Singh, S. M., & Hill, K. A. (2022) · doi:10.2196/preprints.42243
ESTÁGIO NO PROGRAMA O BRASIL CONTA COMIGO DURANTE A PANDEMIA DA COVID-19: UM RELATO DE EXPERIÊNCIA
CHITZ, L., & BORGES, B. E. (2021) · Publicatio UEPG Ciencias Biologicas e da Saude · doi:10.5212/publ.biologicas.v.27.i2.0004
Chen, D., Randhawa, G. S., Soltysiak, M. P. M., de Souza, C. P., Lila Kari, A., Singh, S. M., & Hill, K. A. (2022) · JMIR Bioinformatics and Biotechnology · doi:10.2196/42243
Medical Perspective on COVID-19
Hosseini-Nezhad, P., Hosseini-Nezhad, S., & Hosseini-Nezhad, A. (2023) · Contributions to economics · doi:10.1007/978-3-031-27886-0_2 · Cited by 1
Xiong, Y., Du, L., Wang, J., Wang, Y., Cai, Q., & Xiong, K. (2023) · Lecture notes on data engineering and communications technologies · doi:10.1007/978-3-031-36115-9_52
Quantitative Analysis of Drug from Bulk as Well as Formulation
Deshmukh, O., Mehendre, S., & Nayak, S. (2023) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2023.55297
Foundations of COVID-19 with Focus on Global Comparative Epidemiology
Krämer, A., Rahimitabar, P., & Prüfer-Krämer, L. M. (2023) · Medizin, Kultur, Gesellschaft · doi:10.1007/978-3-658-40525-0_2
Cao, L. (2023) · Data analytics · doi:10.1007/978-981-99-9915-6_10
Modeling Publication Collection and Processing
Cao, L. (2023) · Data analytics · doi:10.1007/978-981-99-9915-6_8
Yang, H., Zhang, X., Li, Y., Deng, J., Liu, Z., Chen, Q., & Zhang, H. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1378709
Yang, Y., Lin, Y.-J., You, S., Lu, T., Chen, C., Wang, W.-M., Ling, M., Chen, S., & Liao, C. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s480086
Lili, W., Xueping, W., Shanpeng, Y., Feiyu, W., & Ba, Y. (2025) · Clinical Otolaryngology · doi:10.1111/coa.14301
Rössler, B., & Steeves, V. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009383851.012
Cohen, J. E. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009383851.015
Wu, X., Liu, J., Zhang, H., Zhou, H., Wang, W., Ma, Y., Shen, S., Cai, X., Huang, A., & Wang, D. (2022) · Figshare · doi:10.6084/m9.figshare.20968451
Mziou, E., Hchaichi, A., Letaief, H., Dhaouadi, S., Safer, M., Mhadhbi, R., Osman, M., Talmoudi, K., Zouayti, A., Oumaima, K., et al. (2026) · COVID · doi:10.3390/covid6080133
Genomic surveillance and evolutionary dynamics of SARS-CoV-2 variants in Yunnan, China, 2022–2025
Yang, M., Liu, Y., Zhang, Z., 杜映荣, 陆霓虹, Yang, X., Zhang, X., Li, J., & Xia, X. (2026) · Biosafety and Health · doi:10.1016/j.bsheal.2026.07.008
BindingDB (2023) · UC San Diego · doi:10.7270/q2s186js
Metadata
- Authors
- Grubaugh, N. D., Hodcroft, E. B., Fauver, J. R., Phelan, A. L., & Cevik, M.
- Affiliations
- Yale University (US)
- University of Bern (CH)
- Georgetown University (US)
- Corresponding author
- Hodcroft, Emma B.
- Fauver, Joseph R.
- Phelan, Alexandra L.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 184
- Issue
- 5
- Pages
- 1127-1132
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC7846239
- OpenAlex
- W3127798546
- Cited by
- 147
- References
- 20
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 11 · 2023: 21 · 2022: 48 · 2021: 56
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 368 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- George Mason University
- Centers for Disease Control and Prevention (75D30120C09570)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Social Sciences › Sociology and Political Science › COVID-19 Prevention and Impact
- Keywords
- SARS-CoV-2 variants, B.1.1.7 variant, Omicron variant, transmissibility, variant surveillance, public health measures, COVID-19 pandemic
- MeSH terms
- COVID-19, SARS-CoV-2, Age Factors, Communicable Disease Control, United Kingdom, Humans, Travel, Global Health, Vulnerable Populations, Mandatory Programs, Pandemics, Epidemiological Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
